Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures

Saurabh Zanwar,Morie A. Gertz,Eli Muchtar,Francis K. Buadi,Taxiarchis Kourelis,Wilson Gonsalves,Ronald S. Go,Suzanne Hayman,Prashant Kapoor,Moritz Binder,Joselle Cook,David Dingli,Nelson Leung,Yi Lin,Rahma Warsame,Amie Fonder,Miriam Hobbs,Yi Lisa Hwa,Robert A. Kyle,S. Vincent Rajkumar,Shaji Kumar,Angela Dispenzieri

DOI: https://doi.org/10.1038/s41375-024-02243-5

2024-04-09

Leukemia

Abstract:Leukemia, Published online: 09 April 2024; doi:10.1038/s41375-024-02243-5 Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures

oncology,hematology